Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.

Pfizer said the structure of the oncology division will remain the same as it shuffles the leadership.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Pfizer projects 2025 revenues of $61-$64 billion, adjusted EPS of $2.80-$3.00, and $24-$26 billion in combined SI&A and R&D expenses while reaffirming its 2024 guidance.

So last year the company created a phone line for doctors and patients to call Pfizer directly for help. Pfizer now credits that and other changes for a 31% increase in Nurtec’s U.S. sales last ...

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with vaccine skeptic Robert F. Kennedy Jr. as the nominee to run the ...

Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the first being declining sales of COVID products, Comirnaty and Paxlovid.

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday. Citing unnamed ...